Cellular uptake and in vivo distribution of mesenchymal-stem-cell-derived extracellular vesicles are protein corona dependent

Revadee Liam-Or,Farid N. Faruqu,Adam Walters,Shunping Han,Lizhou Xu,Julie Tzu-Wen Wang,Jennifer Oberlaender,Alberto Sanchez-Fueyo,Giovanna Lombardi,Francesco Dazzi,Volker Mailaender,Khuloud T. Al-Jamal

DOI: https://doi.org/10.1038/s41565-023-01585-y

IF: 38.3

2024-02-16

Nature Nanotechnology

Abstract:Extracellular vesicles (EVs) derived from mesenchymal stem cells are promising nanotherapeutics in liver diseases due to their regenerative and immunomodulatory properties. Nevertheless, a concern has been raised regarding the rapid clearance of exogenous EVs by phagocytic cells. Here we explore the impact of protein corona on EVs derived from two culturing conditions in which specific proteins acquired from media were simultaneously adsorbed on the EV surface. Additionally, by incubating EVs with serum, simulating protein corona formation upon systemic delivery, further resolved protein corona–EV complex patterns were investigated. Our findings reveal the potential influences of corona composition on EVs under in vitro conditions and their in vivo kinetics. Our data suggest that bound albumin creates an EV signature that can retarget EVs from hepatic macrophages. This results in markedly improved cellular uptake by hepatocytes, liver sinusoidal endothelial cells and hepatic stellate cells. This phenomenon can be applied as a camouflage strategy by precoating EVs with albumin to fabricate the albumin-enriched protein corona–EV complex, enhancing non-phagocytic uptake in the liver. This work addresses a critical challenge facing intravenously administered EVs for liver therapy by tailoring the protein corona–EV complex for liver cell targeting and immune evasion.

materials science, multidisciplinary,nanoscience & nanotechnology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: **How to improve the targeting and immune escape ability of extracellular vesicles (EVs) in the liver by regulating the protein corona of EVs, thereby enhancing their therapeutic effects?**

Specifically, this research focuses on the application of extracellular vesicles (EVs) derived from mesenchymal stem cells (MSCs) in the treatment of liver diseases. Although these EVs have regenerative and immunomodulatory properties, they are rapidly cleared in vivo, especially recognized and cleared by phagocytes such as macrophages. Therefore, researchers explored the influence of the protein corona on EVs, hoping to optimize the composition of the protein corona so that EVs can better avoid phagocytes, increase their uptake in hepatocytes, hepatic sinusoidal endothelial cells and hepatic stellate cells, and thus improve the therapeutic effect.

### Summary of main problems:
1. **The problem of rapid clearance of EVs**: After entering the body, EVs are easily recognized and cleared by phagocytes (such as macrophages), resulting in insufficient accumulation in the target tissue.
2. **The influence of the protein corona**: The protein corona refers to the protein layer adsorbed on the surface of nanoparticles (such as EVs) when they come into contact with biological fluids. Different compositions of the protein corona will affect the behavior of EVs, including their targeting and immune response.
3. **The influence of different culture conditions on EVs**: The study compared EVs produced under two - dimensional (2D) and three - dimensional (3D) culture conditions and found that EVs cultured in 3D had significant differences in the composition of the protein corona, especially in the enrichment of albumin.
4. **The role of albumin**: As part of the protein corona, albumin can help EVs avoid phagocytes, increase their uptake in hepatocytes, and thus improve the therapeutic effect.

### Research conclusions:
By pre - coating albumin to form an albumin - rich protein corona, the uptake of EVs in non - phagocytic cells (such as hepatocytes, hepatic sinusoidal endothelial cells and hepatic stellate cells) in the liver can be significantly increased, while reducing their clearance by phagocytes such as macrophages. This strategy provides new ideas for the development of more effective treatment methods for liver diseases.

### Formula presentation:
The statistical analysis methods involved in the article include:

- **t - test**: It is used to compare the differences between two groups of data, and the formula is:
\[
t=\frac{\bar{x}_{1}-\bar{x}_{2}}{\sqrt{\frac{s_{1}^{2}}{n_{1}}+\frac{s_{2}^{2}}{n_{2}}}}
\]
where \(\bar{x}_{1}\) and \(\bar{x}_{2}\) are the means of the two groups of samples respectively, \(s_{1}^{2}\) and \(s_{2}^{2}\) are the variances of the two groups of samples respectively, and \(n_{1}\) and \(n_{2}\) are the numbers of the two groups of samples respectively.

- **ANOVA (analysis of variance)**: It is used to compare the differences between multiple groups of data, and the formula is:
\[
F = \frac{MS_{\text{between}}}{MS_{\text{within}}}
\]
where \(MS_{\text{between}}\) is the mean square between groups and \(MS_{\text{within}}\) is the mean square within groups.

These statistical methods help researchers verify the behavioral differences of EVs under different treatment conditions and confirm the important role of albumin in improving the targeting of EVs.